Osteoblasts from the toothless (osteopetrotic) mutation in the rat are unable to direct bone resorption by normal osteoclasts in response to 1,25-dihydroxyvitamin D
- PMID: 7491626
- DOI: 10.1016/s0040-8166(05)80066-7
Osteoblasts from the toothless (osteopetrotic) mutation in the rat are unable to direct bone resorption by normal osteoclasts in response to 1,25-dihydroxyvitamin D
Abstract
Osteopetrosis describes a diversified group of metabolic bone disorders characterized by a generalized, skeletal sclerosis resulting from reduced osteoclast-mediated bone resorption. The toothless (tl) osteopetrotic mutation in the rat is characterized by few osteoclasts and the inability to be cured by transplants of hemopoietic stem cells. This implies that the defect(s) responsible for reduced osteoclast activity in tl rats is within the skeletal microenvironment (cells or matrices). Osteoblasts and their products are known to play a role in regulating bone resorption and abnormalities in the osteoblast population in tl rats have been reported. The purpose of this study was to determine whether osteoblasts isolated from tl mutant rats, when cultured with normal osteoclasts, could increase bone resorption (pit formation) in response to stimulation by 1,25 dihydroxyvitamin D (1,25(OH)2D). The addition of 1,25(OH)2D produced a highly significant response in normal osteoblast cocultures but no response in mutant cultures. A dose response study with 1,25(OH)2D (10(-6) to 10(-9)M) revealed that mutant osteoblasts are unable to increase osteoclast activity. These data indicate that the vitamin D receptor-signal transduction pathway in tl rats needs to be examined.
Similar articles
-
Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.Endocrine. 1999 Dec;11(3):309-19. doi: 10.1385/ENDO:11:3:309. Endocrine. 1999. PMID: 10786828
-
Reduced bone resorption in toothless (osteopetrotic) rats--an abnormality of osteoblasts related to their inability to activate osteoclast activity in vitro.Connect Tissue Res. 1996;35(1-4):273-8. doi: 10.3109/03008209609029201. Connect Tissue Res. 1996. PMID: 9084666
-
Interdependence of skeletal sclerosis and elevated circulating levels of 1,25-dihydroxyvitamin D in osteopetrotic (op and tl) rats.Bone. 1994 Sep-Oct;15(5):515-22. doi: 10.1016/8756-3282(94)90275-5. Bone. 1994. PMID: 7980962
-
Recent developments in the understanding of the pathophysiology of osteopetrosis.Eur J Endocrinol. 1996 Feb;134(2):143-56. doi: 10.1530/eje.0.1340143. Eur J Endocrinol. 1996. PMID: 8630510 Review.
-
Advances in osteoclast biology resulting from the study of osteopetrotic mutations.Hum Genet. 2009 Jan;124(6):561-77. doi: 10.1007/s00439-008-0583-8. Epub 2008 Nov 6. Hum Genet. 2009. PMID: 18987890 Review.
Cited by
-
Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.Endocrine. 1999 Dec;11(3):309-19. doi: 10.1385/ENDO:11:3:309. Endocrine. 1999. PMID: 10786828
-
Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant.J Clin Invest. 1996 Oct 15;98(8):1835-42. doi: 10.1172/JCI118984. J Clin Invest. 1996. PMID: 8878435 Free PMC article.
-
The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification.Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14303-8. doi: 10.1073/pnas.202332999. Epub 2002 Oct 11. Proc Natl Acad Sci U S A. 2002. PMID: 12379742 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources